Cross Linking for Treatment of Corneal Infection

• Status: Terminated
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Price Vision Group
• Collaborator: Cornea Research Foundation of America
• Treatments: Riboflavin

Criteria

Inclusion Criteria:

• diagnosis of infectious keratitis

Exclusion Criteria:

• corneal ulcer that has perforated

• corneal ulcer that has produced a descemetocele

• women who are pregnant or breastfeeding

• patients who are immunocompromised or unwilling or unable to comply with a medication regimen